Afaq Motiwala
Interventional Cardiology · Galveston, TXNPI 1205185345
Payments from drug & device makers
Across 153 payments — averaging $107.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$5K
- Edwards Lifesciences$2K
- Medtronic$2K
- Heartflow, Inc.$2K
- Boston Scientific$2K
- Philips North America LLC$1K
- plus $3K from 11 others
What the payments were for
- Consulting fees$680%
- Travel & lodging$8,27450%
- Food & beverage$7,73947%
- Education$3732%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 36 | $5,135 |
| Edwards Lifesciences | 15 | $2,183 |
| Medtronic(2 entities) | 14 | $1,686 |
| Heartflow, Inc. | 7 | $1,596 |
| Boston Scientific | 39 | $1,578 |
| Philips North America LLC | 6 | $1,138 |
| Inari Medical, Inc. | 8 | $963 |
| Baylis Medical Company Inc | 2 | $629 |
| Abiomed | 5 | $343 |
| Shockwave Medical, Inc | 4 | $289 |
| Penumbra, Inc. | 2 | $270 |
| Amgen | 8 | $254 |
| Angiodynamics, Inc. | 2 | $197 |
| Johnson & Johnson | 1 | $97 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $40 |
| Biosense Webster, Inc. | 1 | $35 |
| W. L. Gore & Associates, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIS$1,832
- FFRct$1,447
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,281
- CoreValve Evolut$1,148
- FLOWTRIEVER CATHETER, S$1,134
- US Und$1,039
- PRESSUREWIRE$987
- CT THROMBECTOMY SYSTEM KIT$668
- NRG needle$629
- Omnilink Elite vascular stent system$303
- Indigo System$270
- COROFLOW$247
- OMNILINK ELITE$242
- CROSSBOSS$188
- XIENCE SIERRA$181
- AMPLATZER TALISMAN$176
- ABSOLUTE PRO$174
- DRAGONFLY OPSTAR$159
- MitraClip System$150
- IN.PACT Admiral$146
How this compares
$16,454 in reported general payments places this provider in the 60th percentile of 686 interventional cardiology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 59 | $42,441 |
| Metoprolol Succinate | 75 | $966 |
| Atorvastatin Calcium | 68 | $672 |
| Carvedilol | 34 | $282 |
| Lisinopril | 41 | $280 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 22 | $212 |
| Rosuvastatin Calcium | 16 | $176 |
| ClopidogrelClopidogrel Bisulfate | 20 | $168 |
| Losartan Potassium | 23 | $141 |
| Spironolactone | 13 | $132 |
| Metoprolol Tartrate | 14 | $73 |
| Amlodipine Besylate | 11 | $64 |
| Furosemide | 18 | $59 |
| Hydrochlorothiazide | 13 | $44 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Galveston
- Robert StolerDallas$8.2M
- James ChoiDallas$5.2M
- Srinivasa PotluriPlano$5.1M
- Neal KleimanHouston$4.8M
- Juan GranadaHouston$4.3M
- Ira LieberKingwood$3.3M
- Cara Ann EastDallas$3M
- Abhijeet DhobleHouston$2.7M
- Jeffrey CarrTyler$2.7M
- M Asad KarimMcKinney$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.